loadpatents
name:-0.10672783851624
name:-0.093786954879761
name:-0.013828992843628
Tung; Roger D. Patent Filings

Tung; Roger D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tung; Roger D..The latest application filed is for "4-hydroxybutyric acid analogs".

Company Profile
12.73.96
  • Tung; Roger D. - Lexington MA
  • Tung; Roger D. - Arlington MA
  • Tung; Roger D. - San Diego CA
  • Tung; Roger D - Arlington MA
  • Tung; Roger D - Beverly MA
  • Tung; Roger D. - Beverly MA
  • Tung; Roger D. - Cambridge MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
4-hydroxybutyric Acid Analogs
App 20220162146 - Tung; Roger D.
2022-05-26
4-hydroxybutyric Acid Analogs
App 20210403407 - Tung; Roger D. ;   et al.
2021-12-30
4-hydroxybutyric acid analogs
Grant 11,161,798 - Tung November 2, 2
2021-11-02
Deuterated Analogs Of D-beta-hydroxybutyric Acid And Uses Thereof
App 20210008018 - Tung; Roger D. ;   et al.
2021-01-14
Deuterated Analogs Of D-serine And Uses Thereof
App 20200390732 - Doller; Dario ;   et al.
2020-12-17
4-hydroxybutyric Acid Analogs
App 20200385330 - Tung; Roger D.
2020-12-10
Deuterated Analogs Of D-serine And Uses Thereof
App 20200368193 - Doller; Dario ;   et al.
2020-11-26
Deuterated idebenone
Grant 10,843,993 - Tung November 24, 2
2020-11-24
Deuterated baricitinib
Grant 10,842,792 - Tung November 24, 2
2020-11-24
Deuterated CFTR potentiators
Grant 10,759,721 - Morgan , et al. Sep
2020-09-01
Deuterated CFTR modulators
Grant 10,738,036 - Silverman , et al. A
2020-08-11
Deuterated analogs of D-serine and uses thereof
Grant 10,668,036 - Doller , et al.
2020-06-02
Deuterated Cftr Potentiators
App 20200031776 - Morgan; Adam J. ;   et al.
2020-01-30
4-hydroxybutyric acid analogs
Grant 10,532,971 - Tung Ja
2020-01-14
Deuterated Idebenone
App 20190367438 - Tung; Roger D.
2019-12-05
Deuterated Morphinan Compounds For Treating Agitation
App 20190336494 - Tung; Roger D. ;   et al.
2019-11-07
Deuterated Analogs Of D-serine And Uses Thereof
App 20190328692 - Doller; Dario ;   et al.
2019-10-31
Deuterated GFT-505
Grant 10,442,761 - Tung Oc
2019-10-15
Deuterated Cftr Modulators
App 20190284175 - SILVERMAN; I. Robert ;   et al.
2019-09-19
Deuterated idebenone
Grant 10,343,968 - Tung July 9, 2
2019-07-09
Substituted xanthine derivatives
Grant 10,335,413 - Tung , et al.
2019-07-02
4-hydroxybutyric Acid Analogs
App 20190100484 - Tung; Roger D. ;   et al.
2019-04-04
Deuterated Gft-505
App 20190047949 - Tung; Roger D.
2019-02-14
Deuterated CFTR modulators
Grant 10,196,384 - Silverman , et al. Fe
2019-02-05
Deuterated Idebenone
App 20190016657 - Tung; Roger D.
2019-01-17
Substituted Xanthine Derivatives
App 20180333417 - Tung; Roger D. ;   et al.
2018-11-22
Deuterated Morphinan Compounds For Treating Agitation
App 20180243289 - Tung; Roger D.
2018-08-30
Deuterated Morphinan Compounds For Treating Agitation
App 20180243291 - TUNG; Roger D. ;   et al.
2018-08-30
Morphinan Compounds For Treating Agitation
App 20180243290 - Tung; Roger D. ;   et al.
2018-08-30
Deuterated Baricitinib
App 20180221374 - Tung; Roger D.
2018-08-09
4-hydroxybutyric acid analogs
Grant 10,040,748 - Tung , et al. August 7, 2
2018-08-07
4-hydroxybutyric Acid Analogs
App 20180155266 - Tung; Roger D.
2018-06-07
Deuterated Vx-661
App 20180111920 - SILVERMAN; I. Robert ;   et al.
2018-04-26
Deuterated pyrazino[2,1-a]isoquinoline compounds and methods of treatment using the same
Grant 9,944,635 - Liu , et al. April 17, 2
2018-04-17
Deuterated baricitinib
Grant 9,931,343 - Tung April 3, 2
2018-04-03
Substituted xanthine derivatives
Grant 9,918,987 - Tung , et al. March 20, 2
2018-03-20
Morphinan compounds
Grant 9,868,976 - Tung January 16, 2
2018-01-16
Deuterated rigosertib
Grant 9,840,463 - Tung December 12, 2
2017-12-12
4-hydroxybutyric acid analogs
Grant 9,815,763 - Tung November 14, 2
2017-11-14
Deuterated ibrutinib
Grant 9,777,009 - Tung , et al. October 3, 2
2017-10-03
Inhibitors of cholesterol ester transfer protein
Grant 9,708,277 - Tung July 18, 2
2017-07-18
Derivatives of pyrazole-substituted amino-heteroaryl compounds
Grant 9,707,218 - Pandya , et al. July 18, 2
2017-07-18
Deuterated Baricitinib
App 20170189406 - Tung; Roger D.
2017-07-06
Morphinan Compounds
App 20170037449 - Tung; Roger D.
2017-02-09
Substituted Xanthine Derivatives
App 20170027946 - Tung; Roger D. ;   et al.
2017-02-02
Deuterated Ibrutinib
App 20170015670 - Tung; Roger D. ;   et al.
2017-01-19
Deuterated baricitinib
Grant 9,540,367 - Tung January 10, 2
2017-01-10
Substituted xanthine derivatives
Grant 9,492,457 - Tung , et al. November 15, 2
2016-11-15
Substituted xanthine derivatives
Grant 9,493,463 - Tung , et al. November 15, 2
2016-11-15
4-hydroxybutyric Acid Analogs
App 20160326086 - Tung; Roger D. ;   et al.
2016-11-10
Deuterated ibrutinib
Grant 9,422,295 - Tung , et al. August 23, 2
2016-08-23
Deuterated Rigosertib
App 20160159736 - Tung; Roger D.
2016-06-09
Substituted xanthine derivatives
Grant 9,328,113 - Tung , et al. May 3, 2
2016-05-03
Inhibitors of Cholesterol Ester Transfer Protein
App 20160115138 - Tung; Roger D.
2016-04-28
4-hydroxybutyric acid analogs
Grant 9,309,182 - Tung , et al. April 12, 2
2016-04-12
Pyrazinoisoquinoline Compounds
App 20160083385 - Liu; Julie F. ;   et al.
2016-03-24
Pyrazinoisoquinoline Compounds
App 20160060263 - Liu; Julie F. ;   et al.
2016-03-03
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
Grant 9,260,432 - Tung , et al. February 16, 2
2016-02-16
Deuterated rigosertib
Grant 9,249,093 - Tung February 2, 2
2016-02-02
Inhibitors of cholesterol ester transfer protein
Grant 9,233,938 - Tung January 12, 2
2016-01-12
Derivatives of Pyrazole-Substituted Amino-Heteroaryl Compounds
App 20150366853 - Pandya; Bhaumik A. ;   et al.
2015-12-24
Methods of use comprising deuterated pyrazino[2,1-a]isoquinolines
Grant 9,206,179 - Liu , et al. December 8, 2
2015-12-08
4-hydroxybutyric Acid Analogs
App 20150344398 - Tung; Roger D.
2015-12-03
Deuterated pyrazino[2,1-a]isoquinolines for the treatment of diseases and/or conditions
Grant 9,199,986 - Liu , et al. December 1, 2
2015-12-01
Substituted Dioxopiperidinyl Phthalimide Derivatives
App 20150336927 - Tung; Roger D.
2015-11-26
Substituted Xanthine Derivatives
App 20150322068 - Tung; Roger D. ;   et al.
2015-11-12
Deuterated vercirnon
Grant 9,181,190 - Tung November 10, 2
2015-11-10
Substituted Xanthine Derivatives
App 20150272956 - Tung; Roger D. ;   et al.
2015-10-01
Deuterated Baricitinib
App 20150218158 - Tung; Roger D.
2015-08-06
Deuterated 4-hydroxybutyric Acid Analogs
App 20150210624 - Tung; Roger D. ;   et al.
2015-07-30
Deuterated Ibrutinib
App 20150210699 - Tung; Roger D. ;   et al.
2015-07-30
NOVEL BENZO[d][1,3]-DIOXOL DERIVATIVES
App 20150196544 - Tung; Roger D.
2015-07-16
Deuterated Vercirnon
App 20150175546 - Tung; Roger D.
2015-06-25
Deuterated Idebenone
App 20150166449 - Tung; Roger D.
2015-06-18
4-hydroxybutyric acid analogs
Grant 9,051,261 - Tung June 9, 2
2015-06-09
Pyrazinoisoquinoline Compounds
App 20150141431 - Liu; Julie F. ;   et al.
2015-05-21
Substituted xanthine derivatives
Grant 9,035,050 - Tung , et al. May 19, 2
2015-05-19
Substituted Xanthine Derivatives
App 20150119407 - Tung; Roger D. ;   et al.
2015-04-30
Deuterated Rigosertib
App 20150094276 - Tung; Roger D.
2015-04-02
Deuterium-substituted xanthine derivatives and methods of use
Grant 8,987,442 - Tung , et al. March 24, 2
2015-03-24
Substituted xanthine derivatives
Grant 8,952,016 - Tung , et al. February 10, 2
2015-02-10
Inhibitors of Cholesterol Ester Transfer Protein
App 20150011595 - Tung; Roger D.
2015-01-08
4-hydroxybutyric Acid Analogs
App 20140343119 - Tung; Roger D. ;   et al.
2014-11-20
4-hydroxybutyric acid analogs
Grant 8,759,394 - Tung , et al. June 24, 2
2014-06-24
4-hydroxybutyric Acid Analogs
App 20140142179 - Tung; Roger D.
2014-05-22
Substituted Xanthine Derivatives
App 20140121226 - Tung; Roger D. ;   et al.
2014-05-01
Pyrazinoisoquinoline Compounds
App 20140107127 - Liu; Julie F. ;   et al.
2014-04-17
Deuterated Benzo[d][1,3]-dioxol Derivatives
App 20140018390 - Tung; Roger D.
2014-01-16
Derivatives of dimethylcurcumin
Grant 8,575,221 - Masse , et al. November 5, 2
2013-11-05
Substituted Dioxopiperidinyl Phthalimide Derivatives
App 20130150408 - Liu; Julie F. ;   et al.
2013-06-13
4-hydroxybutyric acid analogs
Grant 8,461,197 - Tung June 11, 2
2013-06-11
Heterocyclic Kinase Inhibitors
App 20130095100 - Tung; Roger D.
2013-04-18
Fluorinated diaryl urea derivatives
Grant 8,410,082 - Liu , et al. April 2, 2
2013-04-02
Aminoquinoline Derivatives
App 20130053333 - Tung; Roger D.
2013-02-28
Azapeptide Derivatives
App 20130041156 - Harbeson; Scott L. ;   et al.
2013-02-14
4-hydroxybutyric Acid Analogs
App 20130012565 - Tung; Roger D. ;   et al.
2013-01-10
Inhibitors Of Serine Proteases, Particularly Hepatitis C Virus Ns3 Protease
App 20130012430 - Tung; Roger D. ;   et al.
2013-01-10
Substituted Derivatives Of Bicyclic [4.3.0] Heteroaryl Compounds
App 20120295925 - Tung; Roger D. ;   et al.
2012-11-22
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 8,314,141 - Tung , et al. November 20, 2
2012-11-20
Prostacyclin Derivatives
App 20120270934 - Masse; Craig E. ;   et al.
2012-10-25
Fluorinated Diaryl Urea Derivatives
App 20120237474 - Liu; Julie F. ;   et al.
2012-09-20
Deuterium substituted xanthine derivatives
Grant 8,263,601 - Tung , et al. September 11, 2
2012-09-11
Azapeptide derivatives
Grant 8,258,309 - Harbeson , et al. September 4, 2
2012-09-04
Substituted Xanthine Derivatives
App 20120202830 - Tung; Roger D. ;   et al.
2012-08-09
Azapeptide Derivatives
App 20120165288 - Harbeson; Scott L. ;   et al.
2012-06-28
4-hydroxybutyric Acid Analogs
App 20120122952 - Tung; Roger D.
2012-05-17
Azapeptide derivatives
Grant 8,158,805 - Harbeson , et al. April 17, 2
2012-04-17
Derivatives Of Dimethylcurcumin
App 20110257271 - Masse; Craig E. ;   et al.
2011-10-20
Inhibitors Of Serine Proteases, Particularly Hepatitis C Virus Ns3 Protease
App 20110112114 - Tung; Roger D. ;   et al.
2011-05-12
Substituted Imidazotriazines
App 20110082147 - Harbeson; Scott L. ;   et al.
2011-04-07
Substituted Xanthine Derivatives
App 20110077255 - Tung; Roger D. ;   et al.
2011-03-31
Substituted Triazolo-pyridazine Derivatives
App 20110065711 - Harbeson; Scott L. ;   et al.
2011-03-17
Substituted Xanthine Derivatives
App 20110059995 - Tung; Roger D. ;   et al.
2011-03-10
Substituted Xanthine Derivatives
App 20110053961 - Tung; Roger D. ;   et al.
2011-03-03
Azapeptide Derivatives
App 20110009355 - Harbeson; Scott L. ;   et al.
2011-01-13
Hydroxyethylamino Sulfonamide Derivatives
App 20100305173 - Harbeson; Scott L. ;   et al.
2010-12-02
Prostacyclin Derivatives
App 20100256240 - Tung; Roger D.
2010-10-07
Novel Sulfonamide Inhibitors Of Aspartyl Protease
App 20100210603 - Tung; Roger D. ;   et al.
2010-08-19
Quinazolines Useful As Modulators Of Ion Channels
App 20100160316 - Gonzalez, III; Jesus E. ;   et al.
2010-06-24
Quinazolines useful as modulators of ion channels
Grant 7,713,983 - Gonzalez, III , et al. May 11, 2
2010-05-11
Sulfonamide inhibitors of aspartyl protease
Grant 7,608,632 - Tung , et al. October 27, 2
2009-10-27
Substituted xanthine derivatives
App 20090239886 - Tung; Roger D. ;   et al.
2009-09-24
Inhibitors Of Serine Proteases, Particularly Hepatitis C Virus Ns3 Protease
App 20090143312 - Tung; Roger D. ;   et al.
2009-06-04
Azapeptide derivatives
App 20090036357 - Harbeson; Scott L. ;   et al.
2009-02-05
Novel sulfonamide inhibitors of aspartyl protease
App 20080293727 - Tung; Roger D. ;   et al.
2008-11-27
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 7,388,017 - Tung , et al. June 17, 2
2008-06-17
Sulfonamide inhibitors of aspartyl protease
Grant 7,321,063 - Tung , et al. January 22, 2
2008-01-22
Quinazolines useful as modulators of ion channels
App 20060217377 - Gonzalez; Jesus E. III ;   et al.
2006-09-28
Novel sulfonamide inhibitors of aspartyl protease
App 20060189810 - Tung; Roger D. ;   et al.
2006-08-24
Modulators of VR1 receptor
App 20050004133 - Makings, Lewis R. ;   et al.
2005-01-06
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
App 20040266731 - Tung, Roger D. ;   et al.
2004-12-30
Novel sulfonamide inhibitors of aspartyl protease
App 20040167116 - Tung, Roger D. ;   et al.
2004-08-26
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
App 20040077600 - Tung, Roger D. ;   et al.
2004-04-22
Sulfonamide inhibitors of aspartyl protease
Grant 6,720,335 - Tung , et al. April 13, 2
2004-04-13
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 6,617,309 - Tung , et al. September 9, 2
2003-09-09
Inhibitors of serine proteases, particularly HCV NS3 protease
Grant 6,608,067 - Tung , et al. August 19, 2
2003-08-19
Prodrugs of aspartyl protease inhibitors
App 20030144217 - Tung, Roger D. ;   et al.
2003-07-31
Novel sulfonamide inhibitors of aspartyl protease
App 20030069222 - Tung, Roger D. ;   et al.
2003-04-10
Novel sulfonamide inhibitors of aspartyl protease
App 20030064977 - Tung, Roger D. ;   et al.
2003-04-03
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
App 20020032175 - Tung, Roger D. ;   et al.
2002-03-14
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 6,265,380 - Tung , et al. July 24, 2
2001-07-24
Sulfonamide inhibitors of aspartyl protease
Grant 5,977,137 - Tung , et al. November 2, 1
1999-11-02
Butyrate prodrugs derived from lactic acid
Grant 5,883,123 - Tung , et al. March 16, 1
1999-03-16
Butyrate prodrugs derived from lactic acid
Grant 5,880,152 - Tung , et al. March 9, 1
1999-03-09
THF-containing sulfonamide inhibitors of aspartyl protease
Grant 5,723,490 - Tung March 3, 1
1998-03-03
Heteroatom functionalized .alpha.-methyl ketones
Grant 5,693,847 - Tung , et al. December 2, 1
1997-12-02
Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
Grant 5,691,372 - Tung , et al. November 25, 1
1997-11-25
Immunosuppressive compounds
Grant 5,665,774 - Armistead , et al. September 9, 1
1997-09-09
Immunosuppressive compounds
Grant 5,622,970 - Armistead , et al. April 22, 1
1997-04-22
Sulfonamide inhibitors of aspartyl protease
Grant 5,585,397 - Tung , et al. December 17, 1
1996-12-17
Immunosuppressive compounds
Grant 5,516,797 - Armistead , et al. May 14, 1
1996-05-14
Immunosuppressive compounds
Grant 5,330,993 - Armistead , et al. July 19, 1
1994-07-19
Immunosuppressive compounds
Grant 5,192,773 - Armistead , et al. March 9, 1
1993-03-09
Company Registrations
SEC0001594857Tung Roger D

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed